John C. Martin
E551391
John C. Martin was an American pharmaceutical executive and scientist best known for leading Gilead Sciences’ rise into a major biopharmaceutical company, particularly in antiviral and HIV/hepatitis C treatments.
All labels observed (1)
| Label | Occurrences |
|---|---|
| John C. Martin canonical | 1 |
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
human
ⓘ
pharmaceutical executive ⓘ scientist ⓘ |
| academicDegree |
MBA
ⓘ
PhD in organic chemistry ⓘ bachelor’s degree in chemical engineering ⓘ |
| countryOfCitizenship | United States of America ⓘ |
| educatedAt |
Purdue University
NERFINISHED
ⓘ
Stanford University ⓘ University of Chicago ⓘ |
| employer | Gilead Sciences NERFINISHED ⓘ |
| fieldOfWork |
HIV treatment
ⓘ
antiviral drugs ⓘ hepatitis C treatment ⓘ pharmaceutical industry ⓘ |
| gender | male ⓘ |
| hasExpertise |
business management
ⓘ
drug development ⓘ organic chemistry ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
commercial success of HIV medications at Gilead Sciences
ⓘ
commercial success of hepatitis C medications at Gilead Sciences ⓘ expanding Gilead Sciences into a major biopharmaceutical company ⓘ strategic focus on antiviral therapeutics ⓘ |
| languageOfWorkOrName | English ⓘ |
| memberOf | Gilead Sciences board of directors NERFINISHED ⓘ |
| notableFor |
development and commercialization of antiviral therapies
ⓘ
leadership of Gilead Sciences ⓘ transforming Gilead Sciences into a leading antiviral company ⓘ |
| notableWork |
leadership in development of HIV antiviral regimens at Gilead Sciences
ⓘ
leadership in development of hepatitis C antiviral regimens at Gilead Sciences ⓘ |
| occupation |
pharmaceutical executive
ⓘ
scientist ⓘ |
| positionHeld |
Chairman of Gilead Sciences
ⓘ
Chief Executive Officer of Gilead Sciences ⓘ President of Gilead Sciences ⓘ |
| residence |
California, United States
ⓘ
surface form:
California
|
| workLocation |
California, United States
ⓘ
surface form:
California
Foster City, California NERFINISHED ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Gilead Sciences